An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
lung in Sus scrofa (2)All 2 Gene records
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
Top results in this bookTable of Contents
Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD: A Systematic Review [Internet].
Dobler CC, Morrow AS, Farah MH, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2019 Oct. (Comparative Effectiveness Review, No. 221.)
The Role of Immunotherapy in the Treatment of Asthma [Internet].
Lin SY, Azar A, Suarez-Cuervo C, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Mar. (AHRQ Comparative Effectiveness Reviews, No. 196.)
Aclidinium Bromide (Tudorza Genuair): Long-term Maintenance Bronchodilator Treatment in Patients with Chronic Obstructive Pulmonary Disease [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Aug.
Reslizumab (Cinqair) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.
Mepolizumab (Nucala) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov.
Fluticasone Furoate/Vilanterol (Breo Ellipta) [Internet].
Clearing the Air: Asthma and Indoor Air Exposures.
Institute of Medicine (US) Committee on the Assessment of Asthma and Indoor Air.
Washington (DC): National Academies Press (US); 2000.
Umeclidinium Bromide/Vilanterol Trifenatate (Anoro Ellipta) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Sep.
Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma [Internet].
Sobieraj DM, Baker WL, Weeda ER, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Mar. (Comparative Effectiveness Reviews, No. 194.)
Clinical Review Report: Benralizumab (Fasenra): (AstraZeneca Canada Inc.): Indication: An add-on maintenance treatment of adult patients with severe eosinophilic asthma [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Aug.
Prevention and Control of Noncommunicable Diseases: Guidelines for Primary Health Care in Low Resource Settings.
Geneva: World Health Organization; 2012.
Clinical Review Report: tiotropium bromide monohydrate and olodaterol hydrochloride (Inspiolto Respimat) for oral inhalation [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Dec.
Clinical Review Report: Fluticasone Propionate (Aermony Respiclick): (Teva Canada Innovation): Indication: For the maintenance treatment of steroid-responsive bronchial asthma as prophylactic therapy in patients 12 years of age and older [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jan.
Clinical Review Report: Omalizumab (Xolair) [Internet].
The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management [Internet].
Wang Z, Pianosi P, Keogh K, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Dec. (Comparative Effectiveness Reviews, No. 197.)
Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma.
National Asthma Education and Prevention Program, Third Expert Panel on the Diagnosis and Management of Asthma.
Bethesda (MD): National Heart, Lung, and Blood Institute (US); 2007 Aug.
Clinical Review Report: Indacaterol Acetate-Glycopyrronium Bromide-Mometasone Furoate (Enerzair Breezhaler): (Novartis Pharmaceuticals Canada Inc.): Indication: Asthma maintenance, adults [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021 Jan.
Effectiveness of Indoor Allergen Reduction in Management of Asthma [Internet].
Leas BF, D’Anci KE, Apter AJ, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Feb. (Comparative Effectiveness Reviews, No. 201.)
Clinical Review Report: Indacaterol/Mometasone Furoate (Atectura Breezhaler): (Novartis Pharmaceuticals Canada Inc.): Indication: Asthma maintenance (adults, children 12 or older) [Internet].
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on